We are live on
!
Find out more
GA
Geneva Advisors Portfolio holdings
AUM
$5.81B
Turnover
22.5%
1-Year Est. Return
23.71%
This Fund
S&P 500
This Quarter
Est. Return
+7.04%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.37B
AUM Growth
+$62.8M
(+1.2%)
Cap. Flow
-$112M
Cap. Flow
% of AUM
-2.09%
Top 10 Holdings %
Top 10 Hldgs %
20.35%
Holding
855
New
121
Increased
189
Reduced
310
Closed
120
Avg Time Held
1
year
Top 10 Avg Time Held
0.6
years
Top 20 Avg Time Held
0.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$45.7M |
| 2 |
Idexx Laboratories
IDXX
|
+$34.3M |
| 3 |
Cardinal Health
CAH
|
+$30.2M |
| 4 |
Applied Materials
AMAT
|
+$24.5M |
| 5 |
Elevance Health
ELV
|
+$24.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$73.1M |
| 2 |
Dover
DOV
|
+$41.7M |
| 3 |
SLB Ltd
SLB
|
+$40M |
| 4 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
+$38.2M |
| 5 |
Wynn Resorts
WYNN
|
+$35.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.73% |
| 2 | Financials | 15.53% |
| 3 | Industrials | 13.23% |
| 4 | Consumer Discretionary | 12.83% |
| 5 | Technology | 10.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
451
Vanguard Morningstar Small-Cap Value ETF
VBR
$35.9B
| $306K | 0.01% |
2,890
-723
| -20% | -$74.6K |
2014 Q1
3 quarters
|
|
452
Eastman Chemical
EMN
$7.12B
| $302K | 0.01% |
3,981
-220
| -5% | -$17.4K |
2014 Q1
3 quarters
|
|
453
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.33B
| $301K | 0.01% |
+8,080
| New | +$236K |
2014 Q4
0 quarters
|
|
454
Dollar Tree
DLTR
$23.2B
| $299K | 0.01% |
4,250
| – | – |
2013 Q3
5 quarters
|
|
|
CTRX
455
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
| $298K | 0.01% |
5,756
-2,534
| -31% | -$119K |
2013 Q2
6 quarters
|
|
456
Distribution Solutions Group
DSGR
$1.62B
| $296K | 0.01% |
22,136
| – | – |
2013 Q2
6 quarters
|
|
|
NPSN
457
DELISTED
NASPERS LTD
NPSN
| $296K | 0.01% |
+2,280
| New | +$296K |
2014 Q4
0 quarters
|
|
458
Vanguard FTSE All-World ex-US ETF
VEU
$67B
| $295K | 0.01% |
6,302
-9
| -0.1% | -$432 |
2013 Q4
4 quarters
|
|
459
iShares Russell 3000 ETF
IWV
$20.2B
| $293K | 0.01% |
2,396
-30
| -1% | -$3.58K |
2013 Q4
4 quarters
|
|
460
Constellation Brands
STZ
$22.2B
| $293K | 0.01% |
2,986
-1,140
| -28% | -$104K |
2013 Q2
6 quarters
|
|
461
Consolidated Edison
ED
$41.5B
| $291K | 0.01% |
4,415
-150
| -3% | -$9.41K |
2014 Q1
3 quarters
|
|
462
Ares Capital
ARCC
$13.5B
| $289K | 0.01% |
18,535
-59,070
| -76% | -$942K |
2014 Q1
3 quarters
|
|
463
AptarGroup
ATR
$7.93B
| $289K | 0.01% |
4,323
+15
| +0.3% | +$951 |
2013 Q2
6 quarters
|
|
|
RHT
464
DELISTED
Red Hat Inc
RHT
| $288K | 0.01% |
4,160
-300
| -7% | -$18.1K |
2014 Q1
3 quarters
|
|
465
Carriage Services
CSV
$577M
| $287K | 0.01% |
13,717
+3,021
| +28% | +$58.2K |
2014 Q3
1 quarter
|
|
466
Occidental Petroleum
OXY
$62.4B
| $287K | 0.01% |
3,570
-750
| -17% | -$62.2K |
2013 Q3
5 quarters
|
|
467
Agilent Technologies
A
$48.6B
| $285K | 0.01% |
6,963
-2,996
| -30% | -$121K |
2014 Q1
3 quarters
|
|
|
RTN
468
DELISTED
Raytheon Company
RTN
| $284K | 0.01% |
2,629
+68
| +3% | +$7.02K |
2013 Q4
4 quarters
|
|
469
Macy's
M
$6.29B
| $283K | 0.01% |
4,306
-2,905
| -40% | -$176K |
2014 Q1
3 quarters
|
|
470
Williams Companies
WMB
$86.3B
| $282K | 0.01% |
6,266
-203
| -3% | -$10.4K |
2014 Q3
1 quarter
|
|
|
BBBY
471
DELISTED
Bed Bath & Beyond Inc
BBBY
| $282K | 0.01% |
3,697
+257
| +7% | +$17.9K |
2014 Q3
1 quarter
|
|
472
DELISTED
CHUBB CORPORATION
CB
| $280K | 0.01% |
2,705
+60
| +2% | +$5.97K |
2013 Q2
6 quarters
|
|
473
DELISTED
PUBLIC STORAGE DEPOSITARY REPSTG PFD SER X (MD)
PSA.PRX
| $277K | 0.01% |
12,000
| – | – |
2014 Q1
3 quarters
|
|
474
Citigroup
C
$208B
| $276K | 0.01% |
5,109
-567
| -10% | -$30.1K |
2013 Q2
6 quarters
|
|
475
iShares US Healthcare Providers ETF
IHF
$1.42B
| $275K | 0.01% |
+11,600
| New | +$261K |
2014 Q4
0 quarters
|
|
Similar funds
CAM
DL
TCM
HCM
AL
AT
Geneva Advisors's Q4 2014 Portfolio in Review
As of Q4 2014, Geneva Advisors held 855 positions worth $5.37B, up 1.2% from $5.31B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Geneva Advisors's Q4 2014 filing shows 121 new, 189 increased, 310 reduced and 120 closed positions. Its largest new stake was Idexx Laboratories: 488,650 shares worth $36.2M. The largest sale was LyondellBasell Industries, an estimated $73.1M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 15% a quarter earlier, followed by Financials and Industrials.
- Geneva Advisors's largest Q4 2014 buy was Idexx Laboratories: 488,650 shares worth $36.2M.
- Geneva Advisors added most to Alibaba in Q4 2014, an estimated $45.7M increase.
- Geneva Advisors's biggest Q4 2014 reduction was LyondellBasell Industries, cutting an estimated $73.1M.
- Geneva Advisors fully exited Community Health Systems in Q4 2014, selling an estimated $13M.
- Geneva Advisors's ten largest holdings make up 20% of its $5.37B portfolio in Q4 2014.
- Geneva Advisors opened 121 new positions and closed 120 in Q4 2014.
- Geneva Advisors's portfolio value rose 1.2% quarter-over-quarter to $5.37B.
Based on Geneva Advisors's 13F filing for Q4 2014, filed 2 Feb 2015.